Clinical trial
Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast…
NCT00458796 · University of Leeds, Other · Terminated
Key facts
| NCT number | NCT00458796 |
|---|---|
| Title | Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone |
| Official title | Cost-Effective Use of Bisphosphonates in Metastatic Bone Disease - A Comparison of Bone Marker Directed Zoledronic Acid Therapy to a Standard Schedule |
| Lead sponsor | University of Leeds, Other |
| Collaborators | University of Sheffield |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer, Musculoskeletal Complications, Pain |
| Intervention type | Drug, Procedure |
| Interventions | zoledronic acid, quality-of-life assessment |
| Enrollment | 1,500 |
| Start date | Mar 1, 2006 |
| First posted | Apr 11, 2007 |
| Last update posted | May 27, 2022 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: